Controlling Sulfur Burps on GLP-1 Medications
Starting a new health journey can feel like a big, positive step forward. But sometimes, our bodies react in ways we don’t expect, leading to moments that can be a little uncomfortable or even embarrassing. For many people starting GLP-1 receptor agonists for type 2 diabetes or weight management, this can mean dealing with digestive […]
GLP-1 Dosing Safety and How Patients Can Avoid Mistakes
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications prescribed for managing type 2 diabetes and, increasingly, for weight loss. These drugs, which include well-known brands like Ozempic, Mounjaro, Zepbound, and Wegovy, represent a significant advancement in treatment. However, their growing popularity has been accompanied by a sharp rise in dosing errors and safety concerns. Understanding GLP-1 […]
Why Your Immune System May Be Fighting Weight Loss
It can be one of the most frustrating experiences: you commit to a healthier lifestyle, you watch what you eat, you increase your activity, but the scale refuses to reward you. This struggle can feel deeply personal, like a failure of willpower. However, emerging science reveals a powerful biological reason why you might feel like […]
GLP-1 Risks Explained Simply
You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and the promotion of weight loss. Some of those headlines feel urgent. Others feel contradictory. One day these medications are described […]
The Hidden Effects of GLP-1 on Women
Until recently most of the talk about the new wave of medications based on GLP-1, such as Wegovy and Zepbound, centered on their positive results. They have demonstrated effectiveness in promoting weight loss in overweight and obese teenagers and adults in the general population. But there’s another side that’s getting the attention of women in […]
Study: GLP-1 drugs do protect muscle during weight loss
Concerns about muscle wasting during rapid weight loss have followed every major breakthrough in weight-loss treatment. With the rise of GLP-1 medicines such as Zepbound (tirzepatide) and Wegovy (semaglutide), that concern has resurfaced, especially as these drugs can produce significant and rapid reductions in body weight. The key question is whether that weight loss comes at […]
Study shows that early use of tirzepatide for diabetes yields cardiac benefits
Early use of tirzepatide appears to improve blood sugar, weight, and several heart-related risk markers in people with recently diagnosed type 2 diabetes. Interim findings from the SURPASS-EARLY trial conducted by Eli Lilly showed that patients treated within four years of diagnosis achieved stronger glycemic control, greater weight loss, and broader metabolic improvements than those receiving […]
Wegovy pill vs Rybelsus: what’s the difference?
“Wegovy pill” is a term that’s gathering a lot of interest on social media platforms. It refers to a new FDA-approved oral semaglutide tablet doctors can prescribe for weight management. This gets attention because most people are aware of the tremendous changes that the introduction of GLP-1 medications such as Ozempic and Wegovy have made in […]
What to do if GLP-1 Medications Reduce Libido
It’s a difficult question to even ask. Can weight-loss wonder drugs like Ozempic and Wegovy also reduce libido? There’s been a wave of fascination, almost a collective obsession, with this new class of GLP-1 drugs, often described as revolutionary. One topic, however, isn’t being discussed nearly enough. It sits quietly beneath the surface, weighed down […]
Is Rybelsus the same as semaglutide?
There has been a tidal wave of interest in the new “wonder drugs” that are based on chemicals called glucagon-like peptide-1 receptor agonists (GLP-1RA), which have revolutionized treatments of a wide range of potentially serious diseases. Many people are now familiar with the common terms associated with these new treatments, such as Ozempic, Mounjaro, semaglutide […]
